First Light Asset Management LLC Reduces Holdings in KORU Medical Systems, Inc. $KRMD

First Light Asset Management LLC cut its position in KORU Medical Systems, Inc. (NASDAQ:KRMD) by 10.5% in the 1st quarter, Holdings Channel.com reports. The firm owned 3,768,380 shares of the company’s stock after selling 442,132 shares during the quarter. KORU Medical Systems comprises 1.5% of First Light Asset Management LLC’s holdings, making the stock its 25th largest position. First Light Asset Management LLC owned approximately 0.08% of KORU Medical Systems worth $16,279,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in KRMD. Simcoe Capital LLC purchased a new stake in KORU Medical Systems during the 4th quarter worth $3,921,000. Geode Capital Management LLC boosted its position in KORU Medical Systems by 101.3% in the 2nd quarter. Geode Capital Management LLC now owns 997,147 shares of the company’s stock valued at $3,571,000 after buying an additional 501,875 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in KORU Medical Systems by 189.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 242,781 shares of the company’s stock valued at $617,000 after buying an additional 158,914 shares during the last quarter. State Street Corp grew its stake in shares of KORU Medical Systems by 32.6% during the fourth quarter. State Street Corp now owns 602,645 shares of the company’s stock valued at $3,501,000 after acquiring an additional 148,166 shares in the last quarter. Finally, Informed Momentum Co LLC acquired a new stake in shares of KORU Medical Systems during the fourth quarter valued at about $794,000. 58.60% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently commented on KRMD. Wall Street Zen upgraded KORU Medical Systems from a “hold” rating to a “buy” rating in a research note on Saturday, July 4th. Weiss Ratings lowered KORU Medical Systems from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, July 15th. Four analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, KORU Medical Systems presently has a consensus rating of “Moderate Buy” and an average target price of $7.25.

Insiders Place Their Bets

In related news, insider Adam R. Kalbermatten acquired 12,500 shares of the firm’s stock in a transaction on Thursday, June 11th. The stock was bought at an average cost of $3.94 per share, with a total value of $49,250.00. Following the acquisition, the insider directly owned 312,500 shares in the company, valued at approximately $1,231,250. The trade was a 4.17% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last ninety days, insiders have acquired 28,000 shares of company stock worth $109,430. 18.50% of the stock is owned by company insiders.

KORU Medical Systems Price Performance

KRMD opened at $3.83 on Monday. The stock has a market capitalization of $175.91 million, a PE ratio of -76.60 and a beta of 0.41. The firm’s fifty day moving average price is $4.12 and its 200 day moving average price is $4.48. KORU Medical Systems, Inc. has a 12-month low of $3.20 and a 12-month high of $6.61.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.